DE3218761A1 - Nonapeptid zur behandlung von suchtmittelentzugserscheinungen - Google Patents

Nonapeptid zur behandlung von suchtmittelentzugserscheinungen

Info

Publication number
DE3218761A1
DE3218761A1 DE3218761A DE3218761A DE3218761A1 DE 3218761 A1 DE3218761 A1 DE 3218761A1 DE 3218761 A DE3218761 A DE 3218761A DE 3218761 A DE3218761 A DE 3218761A DE 3218761 A1 DE3218761 A1 DE 3218761A1
Authority
DE
Germany
Prior art keywords
nonapeptide
withdrawals
addiction
treatment
addiction withdrawals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE3218761A
Other languages
English (en)
Other versions
DE3218761C2 (de
Inventor
Richard Raimund Scherschlicht
Rene Prof Tissot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE3218761A1 publication Critical patent/DE3218761A1/de
Application granted granted Critical
Publication of DE3218761C2 publication Critical patent/DE3218761C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
DE3218761A 1981-05-21 1982-05-18 Nonapeptid zur behandlung von suchtmittelentzugserscheinungen Granted DE3218761A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH330681 1981-05-21

Publications (2)

Publication Number Publication Date
DE3218761A1 true DE3218761A1 (de) 1982-12-16
DE3218761C2 DE3218761C2 (de) 1993-05-06

Family

ID=4253131

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3218761A Granted DE3218761A1 (de) 1981-05-21 1982-05-18 Nonapeptid zur behandlung von suchtmittelentzugserscheinungen

Country Status (11)

Country Link
US (2) US4444758A (de)
EP (1) EP0065747B1 (de)
JP (1) JPS5823630A (de)
AU (1) AU552547B2 (de)
CA (1) CA1188989A (de)
DE (1) DE3218761A1 (de)
IE (1) IE53395B1 (de)
IL (1) IL65782A (de)
IT (1) IT1152116B (de)
PH (1) PH17981A (de)
ZA (1) ZA823369B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US5403595A (en) * 1991-05-07 1995-04-04 Dynagen, Inc. Controlled, sustained release delivery system for smoking cessation
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
ATE510542T1 (de) * 1997-09-04 2011-06-15 Novoneuron Inc Noribogain zur behandlung von schmerzen und drogenabhängigkeit
WO2000045832A2 (en) * 1999-02-05 2000-08-10 The Victoria University Of Manchester Regulation of anaesthesia
DE10014007A1 (de) * 2000-03-22 2001-10-11 Strathmann Ag & Co Neue Darreichungsformen für DSIP
RU2005128993A (ru) * 2005-09-08 2007-03-20 Общество С Ограниченной Ответственностью Исследовательский Центр "Комкон" (Ru) Средство для коррекции стресс-индуцируемых нейромедиаторных, нейроэндокринных и метаболических нарушений, а также способ профилактики и лечения сопутствующих им паталогических состояний
WO2009033814A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
MX2013000733A (es) 2010-07-23 2013-05-30 Demerx Inc Composiciones de noribogaina.
EP2481740B1 (de) 2011-01-26 2015-11-04 DemeRx, Inc. Verfahren und Zusammensetzungen zur Herstellung von Noribogain aus Voacangin
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
WO2013085922A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
WO2013112673A1 (en) 2012-01-25 2013-08-01 Demerx, Inc. Synthetic voacangine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
CA2896133A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828433A1 (de) * 1977-06-30 1979-01-11 Hoffmann La Roche Phosphorylierte nonapeptide und verfahren zu deren herstellung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828433A1 (de) * 1977-06-30 1979-01-11 Hoffmann La Roche Phosphorylierte nonapeptide und verfahren zu deren herstellung

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHIPKIN, R.E., et al.: Pharmacology Biochemistry & Behaviour, Vol. 12, 1, 1980, S. 93-98 *
HERZ, A.: Spektrum der Wissenschaft, Nr. 4, 1980, S. 79-89 *
KASTIN, A.J., et al.: Trends in Neuro Sciences, Vol. 3, 7, 1980, S. 163-165 *
SCHOENENBERGER, G.A., MONNIER, M.: Proc. Natl. Acad. Sci. USA, 74, 3, 1977, S. 1282-1286 *

Also Published As

Publication number Publication date
US4496545A (en) 1985-01-29
CA1188989A (en) 1985-06-18
EP0065747A1 (de) 1982-12-01
EP0065747B1 (de) 1986-10-15
ZA823369B (en) 1983-03-30
JPS5823630A (ja) 1983-02-12
IL65782A (en) 1985-08-30
DE3218761C2 (de) 1993-05-06
PH17981A (en) 1985-02-26
IE821214L (en) 1982-11-21
IT1152116B (it) 1986-12-31
IE53395B1 (en) 1988-11-09
AU8375682A (en) 1982-11-25
US4444758A (en) 1984-04-24
JPH0354089B2 (de) 1991-08-19
AU552547B2 (en) 1986-06-05
IT8221072A0 (it) 1982-05-04
IL65782A0 (en) 1982-08-31

Similar Documents

Publication Publication Date Title
DE3218761A1 (de) Nonapeptid zur behandlung von suchtmittelentzugserscheinungen
ATA907182A (de) Einrichtung zur behandlung von blutgefaessen od.dgl.
DE3869490D1 (de) Verfahren zur elektrochemischen behandlung von stoffen.
DE4391418T1 (de) Vorrichtung zur elektrochemischen Behandlung von Wasser
NO154905C (no) Fremgangsmaate for fremstilling av preparater for behandling av melanomer.
DE3581514D1 (de) Film zur behandlung von halbleiterwaffeln.
IT1211070B (it) Procedimento per il trattamento di lisato di limulo e reagente contenente il lisato trattato.
ATE33098T1 (de) Celiprolol zur behandlung von glaukom.
NO161391C (no) Fremgangsmaate for behandling av kjemisk papirmasse.
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
NO872645D0 (no) Fremgangsmaate for utvinning av flytende naturgasser.
DE3875016T2 (de) Therapeutikum zur behandlung von aids.
DE68912913T2 (de) Vorrichtung zur elektrolytischen Behandlung von metallischen Gegenständen.
NO158797C (no) Fremgangsmaate for behandling av halidholdige avloepsvaesker.
FI851794A0 (fi) Anordning foer neutralisering av syresatt vatten.
NO157828C (no) Behandling av treflis.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE69011065D1 (de) Verfahren zur Behandlung von Nickel-Magnesium-Silikaterzen.
DE3280419T2 (de) Medizinisches praeparat zur behandlung von hautleiden.
ATE55265T1 (de) Vorrichtung zur behandlung von schrammen.
DD139361A1 (de) Verfahren zur behandlung von cerealienstaerke
ATE57094T1 (de) Mittel zur behandlung von erkrankungen der zahnwurzelhaut.
ATE64683T1 (de) Zusammensetzung zur behandlung von haemorroiden.
NO830614L (no) Fremgangsmaate for behandling av glaukom.
RO81791A2 (ro) Comprimate pentru tratamentul uremiilor feriprive

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: F. HOFFMANN-LA ROCHE AG, BASEL, CH

8128 New person/name/address of the agent

Representative=s name: LEDERER, F., DIPL.-CHEM. DR., 8000 MUENCHEN RIEDER

D2 Grant after examination
8364 No opposition during term of opposition